SPN 01
Alternative Names: SPN-01Latest Information Update: 18 Dec 2024
Price :
$50 *
At a glance
- Originator Beijing SonoPhotoNano Medical Technology
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Colorectal cancer
Most Recent Events
- 03 Dec 2024 Beijing SonoPhotoNano Medical Technology plans a phase I trial in Colorectal cancer (IV) (NCT06710561)
- 03 Dec 2024 Preclinical trials in Colorectal cancer in China (IV), before December 2024